GlassScriptPhysician profile
Ryan Isaac Nasseri
NPI 1841853058
$6,871.46
in general payments reported to CMS, 2019-2025
13 companies · $2,452 in 2025
The $2,452 reported for 2025 was more than what 84% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $659 · 2022: $901 · 2023: $800 · 2024: $2,059 · 2025: $2,452.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,603 · Travel and Lodging: $2,558 · Grant: $151.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,602.59 |
| Travel and Lodging | $2,558.19 |
| Grant | $150.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $3,605.68 | 2023-2025 | Restorelle |
| Boston Scientific Corporation | $1,689.69 | 2021-2025 | General - Erectile Dysfunction, Advantage System, Ams 700 |
| Medtronic, INC. | $601.88 | 2021-2024 | Interstim |
| Teleflex LLC | $266.33 | 2023-2024 | Urolift |
| Ambu INC. | $143.77 | 2025 | |
| Endo USA, INC. | $125.37 | 2024 | Xiaflex |
| Ethicon US, LLC | $96.77 | 2022 | |
| Intuitive Surgical, INC. | $78.79 | 2022 | |
| Astellas Pharma US INC | $78.58 | 2021 | |
| Stryker Corporation | $69.79 | 2021 | |
| Procept Biorobotics Corporation | $56.88 | 2024-2025 | Aquabeam System |
| Profound Medical Corp. | $42.30 | 2025 | Tulsa-Pro |
| Tolmar, INC. | $15.63 | 2025 | Jatenzo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Nasseri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.